Dr. Robert G Gish
LightNews LightNews
banner
drrobertgish.bsky.social
Dr. Robert G Gish
@drrobertgish.bsky.social
180 followers 23 following 18 posts
Liver Disease Specialist | Hepatologist | Innovator in Patient Hepatitis Care
Posts Replies Media Videos
drrobertgish.bsky.social
🚨 Call for Late-Breaking Abstracts!
Share your newest hepatitis & antiviral research at #HepDART2025 🌺
📅 Deadline: Nov 17, 2025
📍 Hilton Hawaiian Village, Honolulu
Submit here 👉 informedhorizonseducation.com/abstracts-he...
#Hepatitis #LiverDisease #Virology #HepDART
Abstracts - Hep-DART 2025 — Informed Horizons Education Inc.
informedhorizonseducation.com
November 12, 2025 at 2:16 PM
drrobertgish.bsky.social
📣 Excited for @aasldnews.bsky.social #TLM25 Don’t miss the #HBV / #HDV Special Interest Group events — great science, discussion & networking ahead! See you there!

🗓️ Check the full lineup of member sessions here 👉https://www.aasld.org/the-liver-meeting/your-meeting-your-aasld-community
October 29, 2025 at 7:35 PM
drrobertgish.bsky.social
Attended the Wilson Disease Association's Annual Conference where patients and families, clinicians, researchers, & industry are united by one goal: improving the lives of those affected by Wilson disease 🩺 💙 A collaborative community!

#WilsonDisease #WDAConference #RareDiseaseCommunity
October 27, 2025 at 5:32 PM
drrobertgish.bsky.social
www.hcplive.com/view/interce...
Intercept Voluntarily Withdraws Obeticholic Acid (Ocaliva) for PBC From US Market | HCP Live
Intercept Pharmaceuticals has voluntarily withdrawn obeticholic acid from the US market following a request from the FDA.
www.hcplive.com
September 12, 2025 at 12:33 PM
drrobertgish.bsky.social
Delta hepatitis (HDV) is deadly, neglected, and underfunded.

Our new article calls for HDV to be reclassified as an orphan disease—a key move to drive research, drug development & awareness. It’s time 🦠📣

🔗 journals.lww.com/hepcomm/page...
#HepatitisD #OrphanDisease #LiverHealth #GlobalHealth
A call to reclassify the delta hepatitis virus as an orphan ... : Hepatology Communications
An abstract is unavailable.
journals.lww.com
July 9, 2025 at 12:26 PM
Reposted by Dr. Robert G Gish
d-solve-consortium.bsky.social
📢 New Video! Join Prof. Wedemeyer (Hannover Medical School, #D-SOLVE) as he discusses the symptoms & consequences of untreated #HepatitisD. This video is part of our #Awareness campaign, highlighting the importance of early detection and treatment. Watch now and stay informed! youtu.be/BLnRhVehOlE
youtu.be
February 18, 2025 at 11:02 AM
drrobertgish.bsky.social
New podcast episode! 🎙️ We’re breaking down the HepQuant DuO liver function test – how it works, why it’s a game-changer, and what the results mean for your health. Tune in now! 🎧
drgisheverythingliver.libsyn.com

#LiverHealth #HepQuantDuO #MedicalPodcast #HealthInnovation
February 13, 2025 at 8:45 PM
drrobertgish.bsky.social
New podcast episode! 🎧 I'll explain liver function tests, focusing on direct bilirubin, Gilbert Syndrome, and how to interpret lab results. Learn the difference between liver function and enzyme tests. 🩺
drgisheverythingliver.libsyn.com
#LiverHealth #Bilirubin #GilbertSyndrome #MedEd
January 17, 2025 at 1:09 PM
drrobertgish.bsky.social
Happy New Year! 🎉
I have a new Podcast episode out today: Understanding Hepatitis Delta. Its one of the most dangerous forms of viral hepatitis, and I'll break down everything you need to know about HDV

👉 tune in now and stay informed about the future of HDV care!
drgisheverythingliver.libsyn.com
Liver Disease - Testing & Treatment
This podcast, hosted by renowned hepatologist Dr. Robert Gish, will delve into various topics related to liver disease. These will include hepatitis, cholestatic liver disease, diagnostics, testing me...
drgisheverythingliver.libsyn.com
January 2, 2025 at 9:58 PM
drrobertgish.bsky.social
🚨 New Podcast Alert! 🚨
This week I'm diving deep into the role of statins in managing chronic liver disease. Can they improve outcomes? What does the latest research say? Tune in now! 🎧🩺
drgisheverythingliver.libsyn.com
#LiverHealth #Statins #ChronicLiverDisease
December 21, 2024 at 8:21 PM
drrobertgish.bsky.social
This is the first time that hepatitis B and its health disparities have been prioritized for a major U.S. popular media article - please read and share!

www.newyorker.com/science/anna...

#HepatitisB #HepatitisElimination
A Cancer-Causing Virus Hiding in Millions of Americans
Why does hepatitis B, which can lead to liver cancer, often go undetected, even though tests exist?
www.newyorker.com
December 21, 2024 at 1:28 PM
drrobertgish.bsky.social
@SpeakerJohnson @RepJeffries @SenSchumer @LeaderMcConnell have included the #MCEDAct in the end-of-year health package! This bill has the support of 500+ orgs across the country + nearly 400 members of Congress. It’s time to get cancer screening across the finish line!
December 18, 2024 at 9:41 PM
drrobertgish.bsky.social
New Podcast Alert! 🚨
This week I discuss Cuvrior, the groundbreaking treatment for Wilson disease. 🌟

If you or someone you know is affected by Wilson disease, this is an episode you don’t want to miss!🎧

drgisheverythingliver.libsys.com

#WilsonDisease #Cuvrior
December 5, 2024 at 1:04 PM
drrobertgish.bsky.social
📚✨ Thrilled to announce the publication of "Hepatology: An Evidence-Based Clinical Compendium"! 🎉 I had the privilege of writing Chapter 21 on Hepatitis B with Dr. Robert Wong, Dr. Umesha Boregowda and Dr. Rupinder Mann 📖

Use code BAFF20 for 20% off
shop.elsevier.com/books/hepato...
December 3, 2024 at 4:16 PM
drrobertgish.bsky.social
🌟 I had a great discussion with Dr. Brian McDonough to discuss the vital role of comprehensive care in managing PBC. We explore how early diagnosis can help halt progression and potentially even reverse the disease. A must-watch! 💡👩‍⚕️👨‍⚕️

reachmd.com/programs/gi-...
Comprehensive Care in PBC: Balancing Symptom Management and Disease Progression
Primary biliary cholangitis (PBC) often advances to end-stage liver disease. Fortunately, early diagnosis can help halt progression and potentially even reverse the disease. Dr. Brian McDonough sits d...
reachmd.com
December 2, 2024 at 6:06 PM
drrobertgish.bsky.social
Join me for the "AASLD Highlights 2024" at the INEDSYS Hepatology Club webinar 🌟
🗓 Date: Saturday, November 30
⏰ Time: 8am-10am EST
💻 Where: Online – Register Now!
🔬 I’ll be presenting a session on Hepatitis B: Breakthroughs in Diagnosis and Treatment
👉 Register: us06web.zoom.us/meeting/regi...
November 26, 2024 at 3:12 PM
drrobertgish.bsky.social
New article!📰
"Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study"
MASH: Costs are high, intervention may save 💰, lives and improve (?) quality of life
Read here: becarispublishing.com/doi/10.57264...
Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study
Aim: Non-alcoholic steatohepatitis (NASH), or metabolic dysfunction-associated steatohepatitis (MASH), is a severe form of non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated...
becarispublishing.com
November 25, 2024 at 9:34 PM
drrobertgish.bsky.social
🎙️ New Podcast Alert: Noninvasive Testing for Liver Disease 🎙️
🌟 Learn about:
- How NITs help stage liver disease
- Assessing liver fat, inflammation, and disease activity
This episode is a must-listen! 🎧
🔗 drgisheverythingliver.libsyn.com
#NoninvasiveTesting #LiverDisease #NITs #LiverCare #Fibrosis
Liver Disease - Testing & Treatment
This podcast, hosted by renowned hepatologist Dr. Robert Gish, will delve into various topics related to liver disease. These will include hepatitis, cholestatic liver disease, diagnostics, testing me...
drgisheverythingliver.libsyn.com
November 23, 2024 at 12:52 PM
drrobertgish.bsky.social
Through the hepatitis B SIG I am going to ask for a Hepatitis guidance for hepatitis B since the new guidelines will be delayed and very restricted from the aASLD due to PICO and budget
November 23, 2024 at 2:11 AM